Clinical trial
Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL) - A Phase I/II Trial With Concomitant Evaluation of Safety and Efficacy
NCT00951457 is registered in ClinicalTrials.gov with Arbeitsgemeinschaft medikamentoese Tumortherapie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL) - A Phase I/II Trial With Concomitant Evaluation of Safety and Efficacy
- Lead sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- August 6, 2012
- Enrollment
- 20 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.